Table 1.

Presence of fatigue at the time of enrollment by selected clinical, virological and histologic features.

	n	Fatigue (n, %)	p value
Total	401	207 (52%)
Gender:
Male	261	124 (48%)	0.02*
Female	140	83 (59%)
Race:
White	205	113 (55%)	0.15
Black	196	94 (48%)
Age:
<40 years	49	25 (51%)
>40 years	352	182 (51%)	0.93
BMI:
<25	95	46 (48%)
25–30	149	78 (52%)	0.64
>30	150	77 (51%)	0.86
ALT:
<40U/L	68	36 (53%)
40–100U/L	220	116 (53%)	0.77
>100U/L	111	55 (50%)	0.58
AST:
<30U/L	58	30 (52%)
30–100U/L	283	147 (52%)	0.97
>100U/L	58	30 (52%)	0.98
HCV genotype:
1a	210	115 (55%)
1b	148	73 (49%)	0.98
HCV RNA:
>400,000	31	18 (58%)
<400,000	368	188 (51%)	0.46
HAI Score:
1–5	34	17 (50%)
5–10	163	86 (53%)	0.71
11–18	202	103 (51%)	0.95
Fibrosis:
0–2	253	125 (49%)
3–4	117	62 (53%)	0.49
5–6	29	19 (66%)	0.14

^*p<0.05